Skip to main content
Clinical Trials/NCT07375121
NCT07375121
Recruiting
Not Applicable

Prospective Randomized Controlled Study of Individualized PCA Model Based on Multi-dimensional Strategies (Fixed-rate Basal Infusion Mode and Time-programmed Decremental Background Infusion Mode)

Beijing Tiantan Hospital1 site in 1 country450 target enrollmentStarted: December 30, 2025Last updated:

Overview

Phase
Not Applicable
Status
Recruiting
Sponsor
Beijing Tiantan Hospital
Enrollment
450
Locations
1
Primary Endpoint
Cumulative opioid consumption

Overview

Brief Summary

Perioperative pain management affects patient recovery. However, the rate of moderate to severe postoperative pain is as high as 73.8%, which hinders recovery and increases the risk of complications. Although opioids are the first-line analgesics, excessive use leads to adverse reactions. The traditional fixed-rate PCA mode is difficult to match the changes in postoperative pain. This study will compare different PCA mode optimization strategies, assuming that they can reduce opioid dosage, improve analgesic effect, and reduce adverse reactions, providing high-quality evidence-based basis for postoperative analgesia and promoting individualized and intelligent management.

Detailed Description

Perioperative pain management significantly impacts patient recovery outcomes. However, the incidence of moderate to severe postoperative pain remains high at 73.8%, which impedes recovery and increases complication risks. Although opioids serve as first-line analgesics, excessive use causes numerous adverse reactions. The traditional fixed-rate Patient-Controlled Analgesia (PCA) mode fails to adapt to dynamic postoperative pain variations. This study will compare different PCA optimization strategies, hypothesizing that these approaches can reduce opioid dosage, enhance analgesic effectiveness, and minimize adverse reactions. The research aims to provide evidence-based foundations for postoperative analgesia, promoting individualized and intelligent pain management systems that better serve patient needs throughout recovery.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • aged between 18 to 65 years;
  • American Society of Anesthesiologists physical status Ⅰ - Ⅲ;
  • Patients scheduled for elective mixed surgery were enrolled. Mixed surgeries included thoracoscopic surgery, laparoscopic surgery, hysteroscopy surgery, laparotomy, thoracotomy, open spinal surgery, craniotomy, and so on.

Exclusion Criteria

  • Chronic pain syndromes;
  • Psychiatric disorders;
  • Severe cardiovascular or cerebrovascular disease, renal or hepatic functional dysfunction, or allergic to PCA medications.

Arms & Interventions

Fixed-rate basal infusion mode group

Active Comparator

Intervention: Fixed-rate basal infusion mode (Procedure)

time-programmed decremental background infusion mode group

Experimental

Intervention: Time-programmed decremental background infusion mode (Procedure)

Outcomes

Primary Outcomes

Cumulative opioid consumption

Time Frame: Within the first 48 hours postoperatively

Cumulative opioid consumption

Time Frame: Within the first 24 hours postoperatively

Secondary Outcomes

  • Bolus demand frequency(at 1, 6, 12, 24, and 48 hours postoperatively)
  • Cumulative patient-controlled analgesia volume consumption(Within the first 48 hours postoperatively)
  • Frequency of additional rescue analgesics(At 1, 6, 12, 24, and 48 hours postoperatively)
  • Dosage of additional rescue analgesics(At 1, 6, 12, 24, and 48 hours postoperatively)
  • The level of sedation and agitation(At 1, 6, 12, 24, and 48 hours postoperatively)
  • The degree of nausea and vomiting(At 1, 6, 12, 24, and 48 hours postoperatively)
  • The patient's satisfaction with patient-controlled analegsia device(At 48 hours postoperatively)
  • Resting and movement pain score was assessed by numeric rating scale.(At 1, 6, 12, 24, and 48 hours postoperatively)
  • Cumulative patient-controlled analgesia volume consumption(Within the first 24 hours postoperatively)
  • Frequency of additional rescue analgesics(At 12, 24, and 48 hours postoperatively)
  • Dosage of additional rescue analgesics(At 12, 24, and 48 hours postoperatively)
  • Postoperative quality of recovery(At 24, and 48 hours postoperatively)
  • Quality of sleep(At 24, and 48 hours postoperatively)
  • The level of sedation and agitation(At 12, and 24 hours postoperatively)
  • The degree of nausea and vomiting(At 12, 24, and 48 hours postoperatively)
  • The patient's satisfaction with patient-controlled analegsia device(At 24 hours postoperatively)

Investigators

Sponsor
Beijing Tiantan Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Fang Luo

Director, Department of Pain Management, Principal Investigator, Clinical Professor

Beijing Tiantan Hospital

Study Sites (1)

Loading locations...

Similar Trials